Compatibility between Paclitaxel and Polymer Carrier

Article Preview

Abstract:

Several polymer-based drug delivery systems are being developed to enhance the extremely low water-solubility of paclitaxel (PTX). It is believed that there is a positive correlation between the compatibility of polymer-drug and the solubilization. In recent years, solubility parameters for polymer and drug were used to evaluate degree of compatibility between a drug and a polymer, which were measured using various experimental methods or estimated using the group contribution menthod (GCM). In this study, degree of compatibility between PTX and polymers were estimated by molar free energy of mixing (Δ̗mix) that was calculated through computer simulation. It is found that the degree of compatibility is: PTX-PTRP > PTX-PLBG > PTX-PLGA > PTX-PCL > PTX-PLA. It has been demonstrated that the result of this study is in accord with the Similar Dissolve Mutually Theory.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

263-268

Citation:

Online since:

September 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] K. Miller, M.L. Wang, J. Gralow, et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N. Engl. J. Med.,  26 (2007): 2666-2676.

DOI: 10.1056/nejmoa072113

Google Scholar

[2] Y. Zhang, H. Zhang, X.Q. Zhang, et al. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials. 33(2012): 679-691.

DOI: 10.1016/j.biomaterials.2011.09.072

Google Scholar

[3] D.M. Vyas, H. Wong, A.R. Crosswell, et al. Synthesis and antitumor evaluation of water soluble taxol phosphates. Bioorg. Med. Chem. Lett., 3(1993): 1357-1360.

DOI: 10.1016/s0960-894x(00)80348-0

Google Scholar

[4] G. J Fetterly, R.M. Straubinger. Pharmacokinetics of paclitaxel-containing lipo-somes in rats. AAPS Pharm. Sci., 5(2003): E32.

Google Scholar

[5] M.J. Edelman. Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer. Clin. Lung Cancer. 10(2009): 30-34.

DOI: 10.3816/clc.2009.s.005

Google Scholar

[6] S.C. Lee, C. Kim, I.C. Kwon, et al. Polymeric micelles of poly(2-ethyl-2-oxazoline)- block-poly(caprolactone) copolymer as a carrier for paclitaxel. J. Control. Release, 89(2003): 437-446.

DOI: 10.1016/s0168-3659(03)00162-7

Google Scholar

[7] J. Liu, Y.H. Xiao, C. Allen. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J. Pharm. Sci. 93(2004): 132-143.

DOI: 10.1002/jps.10533

Google Scholar

[8] Flory PJ. Principles of polymer chemistry. Ithaca: Cornell University Press(1953).

Google Scholar